Diagnostics, Inc. (NYSE:DGX) Files An 8-K Changes in Registrant’s Certifying AccountantItem 4.01 Change in Registrant’s Certifying Accountant.
(b) On December 14, 2016, ERBA Diagnostics, Inc. (the “Company“) appointed Morrison, Brown, Argiz & Farra, LLC (“MBAF”), as its new independent registered public accounting firm. The decision to appoint MBAF was made and approved by the Audit Committee of the Company’s Board of Directors. MBAF succeeds Mayer Hoffman McCann P.C. (“MHM”) as the Company’s independent registered public accounting firm, which relationship with MHM ceased on August 31, 2016, as previously reported.
During the fiscal years ended December 31, 2016 and 2015 and the interim period through December 14, 2016, the Company has not consulted with MBAF regarding: (i) either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and either a written report was provided to the Company or oral advice was provided that MBAF concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a “disagreement,” as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a “reportable event,” as that term is defined in Item 304(a)(1)(v) of Regulation S-K.
About Diagnostics, Inc. (NYSE:DGX)
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company’s Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company’s Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians’ health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company’s enterprise content management system for hospitals. Diagnostics, Inc. (NYSE:DGX) Recent Trading Information
Diagnostics, Inc. (NYSE:DGX) closed its last trading session up +0.23 at 92.60 with 840,351 shares trading hands.